Compliance as per Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026.
Oxygenta Pharmaceutical Limited Press Release Jul 14 2026
Earlier from Oxygenta Pharmaceutical
- Oxygenta Pharmaceutical Limited Press Release Jun 24 2026
- Oxygenta Pharmaceutical Limited Press Release May 26 2026
- Oxygenta Pharmaceutical Limited Press Release May 23 2026
- Oxygenta Pharmaceutical Limited Press Release May 19 2026